Richmond Pharmacology has appointed Daniel Chapple as Commercial Director. In his role, Chapple will oversee sales, account management, proposals, contracts and marketing – including participant recruitment marketing activities.
Chapple joins Richmond with more than 25 years of commercial leadership experience across the life sciences sector, spanning clinical development, patient engagement, technology and consultancy organisations. Most recently, he served as Chief Business Officer and Chief Partnership Officer at DontBePatient Intelligence. Prior to this, he held senior commercial leadership positions at Alira Health, Innovative Trials, Cognizant and ICON.
During almost a decade as Chief Commercial Officer at Quanticate, Chapple led the commercial function through a period of significant growth.
In his new role, Chapple will lead Richmond’s commercial strategy, supporting the organisation’s continued expansion and helping more sponsors access Richmond’s expertise, diverse participant population and proven track record in clinical research.
Jorg Taubel, CEO and Co-Founder of Richmond Pharmacology, said: “Daniel brings a unique combination of scientific expertise, commercial leadership and a deep understanding of the clinical research landscape.”
Chapple commented: “My focus will be on strengthening partnerships with sponsors, enhancing the client experience and helping to expand Richmond’s role in delivering high-quality clinical research that ultimately benefits patients.”